Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KZR Kezar Life Sciences Inc.

Post-Mkt 04-08 16:53:09 EDT

7.38

-0.01

-0.14%

盘后7.38

+0.000.00%

16:10 EDT

High7.50	Low7.37	Vol112.78K
Open7.42	D1 Closing7.39	Amplitude1.76%
Mkt Cap54.40M	Tradable Cap34.62M	Total Shares7.37M
T/O835.03K	T/O Rate2.40%	Tradable Shares4.69M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":7.38,"timestamp":1775678400000,"preClose":7.39,"halted":0,"volume":112776,"hourTrading":{"tag":"盘后","latestPrice":7.38,"preClose":7.38,"latestTime":"16:10 EDT","volume":10639,"amount":78515.81999999999,"timestamp":1775679004114,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0013531799729363718,"floatShares":4691522,"shares":7371527,"eps":-7.66,"marketStatus":"Post-Mkt","change":-0.01,"latestTime":"04-08 16:53:09 EDT","open":7.42,"high":7.5,"low":7.37,"amount":835027.9319,"amplitude":0.017591,"askPrice":7.6,"askSize":100,"bidPrice":7.2,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-7.66,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1775692800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":7.39,"preHourTrading":{"tag":"盘前","latestPrice":7.6,"preClose":7.39,"latestTime":"09:13 EDT","volume":81,"amount":601.80003,"timestamp":1775654011559,"change":0.21,"changeRate":0.028417,"amplitude":0.027064},"postHourTrading":{"tag":"盘后","latestPrice":7.38,"preClose":7.38,"latestTime":"16:10 EDT","volume":10639,"amount":78515.81999999999,"timestamp":1775679004114,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.296365,"impliedVol":1.3875,"impliedVolPercentile":0.516},"requestUrl":"/m/hq/s/KZR/tweets","defaultTab":"tweets","newsList":[{"id":"2625919790","title":"Kalamazoo Director Increases Equity Stake with On-Market Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2625919790","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625919790?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:29","pubTimestamp":1775636962,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an update. Kalamazoo Resources Ltd. has reported a change in director Benjamin Ackerman’s holding...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-director-increases-equity-stake-with-on-market-share-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-director-increases-equity-stake-with-on-market-share-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","EQR","BK4139","BK4585","BK4588","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624625662","title":"Kezar Life Sciences Announces Major Executive Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2624625662","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624625662?lang=en_us&edition=fundamental","pubTime":"2026-04-04 05:27","pubTimestamp":1775251641,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences ( ($KZR) ) has issued an announcement. On April 1, 2026, Kezar Life Sciences terminated its lease for 48,714 square feet of off...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-announces-major-executive-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-announces-major-executive-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624664225","title":"Aurinia Pharma to buy Kezar Life Sciences for $6.955 a share plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2624664225","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624664225?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:58","pubTimestamp":1775249915,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals agreed to acquire Kezar Life Sciences for USD 6.955 per share in cash plus a non-transferable contingent value right.CVR provides potential payouts tied to development or disposition of Kezar lead asset zetomipzomib, selected collaboration and asset-sale proceeds, and net cash above USD 50 million at closing.Aurinia plans to launch a tender offer by April 13, 2026, for all outstanding Kezar shares.Closing is expected in Q2 2026, subject to a majority of shares tendered and Kezar meeting a net-cash condition above USD 50 million.Tang Capital Partners, holding about 9.0% of Kezar shares, signed a tender and support agreement backing transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurinia Pharmaceutical","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL9hGLjS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZR","AUPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624664400","title":"Kezar Life Sciences CEO Kirk, CFO Belsky, COO Schiller exit under separation agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2624664400","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624664400?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:50","pubTimestamp":1775249410,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences entered separation agreements on April 1, 2026 with Chief Executive Officer Christopher J. Kirk, Chief Financial Officer Marc L. Belsky, and Chief Operating Officer Mark Schiller.Employment for all three executives will terminate at effective time specified in the agreements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kezar Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDLc2qBx4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623321125","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623321125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623321125?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:50","pubTimestamp":1774903807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aura Biosciences Inc (AURA) and Kezar Life Science...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aura-biosciences-inc-aura-and-kezar-life-sciences-kzr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aura-biosciences-inc-aura-and-kezar-life-sciences-kzr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","LABU","LU0029874061.USD","KZR","BK4585","LU0128526141.USD","BK4588","XBI","AURA","BK4581","XLV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326235","title":"Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326235?lang=en_us&edition=fundamental","pubTime":"2026-03-31 03:56","pubTimestamp":1774900569,"startTime":"0","endTime":"0","summary":"After Aurinia Pharmaceuticals (AUPH) announced an agreement to acquire Kezar Life Sciences (KZR) for $6.955 in cash per share plus one non-transfer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kezar-life-sciences-takeover-valuation-makes-sense-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kezar-life-sciences-takeover-valuation-makes-sense-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR","AUPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623342665","title":"BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar","url":"https://stock-news.laohu8.com/highlight/detail?id=2623342665","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623342665?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:53","pubTimestamp":1774886000,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, KezarWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL6N40I13J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEVO","NEMG","XOMO","SR","XOMX","DVN","KALU","CG","CENX","SOC","NEM","RARE","UTHR","CDE","CART","BX","PWR","APO","MMYT","PUMP","ZYME","KKR","GPI","IDYA","BIIB","CNTB","VRDN","CRWD","INSM","FLEX","SYY","GM","EXPE","BSX","HL","BFLY","NVAX","ALK","KZR","CL","ADMA","ADNT","ALV","SSII","AA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623349259","title":"Kezar Life Sciences to Be Acquired by Aurinia","url":"https://stock-news.laohu8.com/highlight/detail?id=2623349259","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623349259?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:26","pubTimestamp":1774880766,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Kezar Life Sciences ( ($KZR) ). On March 30, 2026, Kezar Life Sciences agreed to be acquired by Aurinia Pharmac...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-to-be-acquired-by-aurinia-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-to-be-acquired-by-aurinia-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623317885","title":"Aurinia to buy Kezar Life Sciences for USD 6.96 per share plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2623317885","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623317885?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:03","pubTimestamp":1774872182,"startTime":"0","endTime":"0","summary":"Aurinia agreed to acquire Kezar Life Sciences for USD 6.96 per share in cash.Kezar shareholders will also receive a non-transferable CVR tied to potential proceeds from zetomipzomib development or disposition, select collaboration and asset-sale proceeds, and excess closing net cash above USD 50 million.Aurinia plans to launch tender offer by April 13, 2026, for all outstanding Kezar shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurinia Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL3PZ9wx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AUPH","KZR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623736312","title":"Aurinia Pharmaceuticals Inc - CVR Includes Payments From Zetomipzomib, Everest, Enodia, and Net Cash Over $50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623736312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623736312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:00","pubTimestamp":1774872006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA61LWRC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KZR","AUPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312135","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312135","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312135?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:55","pubTimestamp":1774871700,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:55 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nAQN2LSEZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622083438","title":"Kezar Life Sciences FY2025 operating loss narrows 34.8% to $(59) million; net loss narrows 33.1% to $(56) million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622083438","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622083438?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:16","pubTimestamp":1774642604,"startTime":"0","endTime":"0","summary":"Kezar published its annual report on Form 10-K, reporting a net loss of USD 56 million.Research and development expense fell 48.55% to USD 33.8 million, primarily due to lower clinical expenses after terminating the PALIZADE trial and completing the PORTOLA trial.General and administrative expense declined 20.94% to USD 18.5 million, driven mainly by lower stock-based compensation and personnel costs following restructuring.Restructuring and impairment charges rose more than tripled to USD 6.8 million, reflecting one-time severance costs and higher impairment on equipment no longer used after restructuring.Cash and cash equivalents were USD 71.9 million, and management said this is expected to fund projected operating requirements for at least the next 12 months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL8DXwND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621080046","title":"Kalamazoo starts 14,000m infill drilling to advance Mt Olympus PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080046?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:39","pubTimestamp":1774305547,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an announcement. Kalamazoo Resources has launched a major ~14,000-metre infill drilling campaign ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-starts-14000m-infill-drilling-to-advance-mt-olympus-pfs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-starts-14000m-infill-drilling-to-advance-mt-olympus-pfs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139","BK4195","BK4211","PFS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084103","title":"Top News Today/Canada: Bank of Canada to Lose Two Members of Rate-Setting Governing Council","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084103?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:30","pubTimestamp":1774297800,"startTime":"0","endTime":"0","summary":"The Bank of Canada said that two members of its rate-setting governing council are departing, and it intends to fill the vacancies internally.The central bank said that Deputy Governor Rhys Mendes would leave on April 10, to relocate to Toronto with his family. He was responsible for the central bank's analysis of international economic developments.Deputy Governor Sharon Kozicki intends to retire on July 15, following a two-decade career at Canada's central bank. She was responsible for overseeing analysis of domestic economic developments.BOC Speech Takes on Heightened Importance Amid Rapid Turn in Rate Expectations. LaGuardia Airport Reopens Hours After Deadly Runway Collision. New York City's LaGuardia Airport was closed Monday after a passenger jet collided with an emergency vehicle on the runway, killing two pilots and injuring dozens of other people.The two pilots of the Air Canada Express plane were killed in the crash shortly before midnight Sunday, and a further 41 people, in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MXCT","NKTX","BK4104","BK4007","AIR","BK4198","SFES","BK4213","BK4505","BK4139","LENZ","INTZ","EPSN","IE00B19Z4B17.USD","LU2089985449.USD","CNM","GUTS","BK4187","IE0009354923.USD","SMTI","LU2065169927.USD","ACHV","KZR","BK4588","TIL","ATOS","BK4161","LU2125910336.SGD","BK4135","LU2065170008.USD","ABSI","COLFF","BK4572","IE00B7SZL793.SGD","BK4082","LU2125910179.SGD","LU2065171402.SGD","CNXC","ECTM","AIRJ","BZAI","PAYS","KBH","BRZE","BK4023","LU1923621640.USD","BK4539","BK4141","PVL","SFD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621741168","title":"Kalamazoo’s Ashburton drilling extends Mt Olympus gold mineralisation","url":"https://stock-news.laohu8.com/highlight/detail?id=2621741168","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621741168?lang=en_us&edition=fundamental","pubTime":"2026-03-23 05:39","pubTimestamp":1774215575,"startTime":"0","endTime":"0","summary":"An update from Kalamazoo Resources Ltd. ( ($AU:KZR) ) is now available. Kalamazoo Resources has reported strong initial assay results from its Phas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoos-ashburton-drilling-extends-mt-olympus-gold-mineralisation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoos-ashburton-drilling-extends-mt-olympus-gold-mineralisation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DZZ","BK4535","JNUG","1OZmain","XME","GDXJ","GDXD","AAAU","BK4504","BK4588","IAUM","BK4585","SGOL","GLL","BK4139","BK4207","GLDM","KZR","DGP","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620736165","title":"Kezar Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620736165","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620736165?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:49","pubTimestamp":1774010947,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences Inc  expected to post a loss of $1.23 a share - Earnings Preview Kezar Life Sciences Inc KZR.OQ KZR.O is expected to  show no change in quarterly revenue when it reports  results o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N40817A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620235115","title":"Kalamazoo Resources Issues 10 Million Unquoted Options at $0.255","url":"https://stock-news.laohu8.com/highlight/detail?id=2620235115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620235115?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:18","pubTimestamp":1773821880,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. ( ($AU:KZR) ) has shared an update. Kalamazoo Resources has notified the market of the issuance of 10,000,000 unquoted opt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-10-million-unquoted-options-at-0-255?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-10-million-unquoted-options-at-0-255?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620235184","title":"Kalamazoo Resources Issues New Performance Rights to Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2620235184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620235184?lang=en_us&edition=fundamental","pubTime":"2026-03-18 16:17","pubTimestamp":1773821857,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Kalamazoo Resources Ltd. ( ($AU:KZR) ). Kalamazoo Resources has disclosed a change in director Benjamin Ackerma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-performance-rights-to-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-performance-rights-to-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619777158","title":"BUZZ-U.S. STOCKS ON THE MOVE  -Natera, Pacira BioSciences, Kezar Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2619777158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619777158?lang=en_us&edition=fundamental","pubTime":"2026-03-12 23:59","pubTimestamp":1773331150,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE  -Natera, Pacira BioSciences, Kezar Life SciencesWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning Ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL6N40014H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMBL","LU0320765646.SGD","INTS","LU0175139822.USD","AAL","CF","KKR","SM","XOMO","MUR","DOW","TBBK","OWL","ARES","AALG","JBL","KZR","RPID","LU1868837565.USD","UAL","SG9999014898.SGD","SPRC","WLTH","BK4121","PCRX","DKS","LUV","CE","GYRE","XOMX","CUBI","GIII","XOMZ","BBW","DG","DAL","BX","MELI","IE0002270589.USD","KMLI","CASH","MOS","NOG","SG9999014906.USD","LU1116320737.USD","NTRA","GFS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618322041","title":"Corrected-Enodia Therapeutics - Kezar to Receive $1 Mln Upfront and up to $127 Mln in Milestone Payments (Adds Dropped Word 'Kezar')","url":"https://stock-news.laohu8.com/highlight/detail?id=2618322041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618322041?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:15","pubTimestamp":1773321304,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL8N4001LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KZR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0648},{"period":"3month","weight":0.173},{"period":"6month","weight":0.6795},{"period":"1year","weight":0.6989},{"period":"ytd","weight":0.1749}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":-0.0196},{"period":"3month","weight":-0.044},{"period":"6month","weight":-0.0178},{"period":"1year","weight":0.307},{"period":"ytd","weight":-0.0333}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.084723},{"month":2,"riseRate":0.75,"avgChangeRate":0.08063},{"month":3,"riseRate":0.375,"avgChangeRate":-0.075957},{"month":4,"riseRate":0.25,"avgChangeRate":-0.072624},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.16242},{"month":6,"riseRate":0.428571,"avgChangeRate":0.046939},{"month":7,"riseRate":0.25,"avgChangeRate":-0.059399},{"month":8,"riseRate":0.5,"avgChangeRate":-0.012192},{"month":9,"riseRate":0.375,"avgChangeRate":0.031351},{"month":10,"riseRate":0.375,"avgChangeRate":0.02054},{"month":11,"riseRate":0.75,"avgChangeRate":0.152848},{"month":12,"riseRate":0.5,"avgChangeRate":0.034727}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}